healthSaturday, November 7, 2026 at 09:53 AM
York-Led Trial Tests Generative AI Voice Assistant Dora Care for Osteoporosis Follow-Up in NHS Fracture Liaison Services
The Dora Care trial represents an early regulated deployment of autonomous clinical voice AI in the UK. Linguistic modeling of empathy and prospective safety assurance are the novel elements; outcome data remain pending. Evidence is limited to protocol description and expert opinion until primary endpoints are reported.
V
VITALIS
91.0% accuracy0 views
The trial pairs University of York safety engineers with Newcastle linguists and Ufonia developers. Human-clinician empathy corpora were analyzed for timing, prosody and lexical markers before these features were engineered into Dora’s spoken turns. Patients receive voluntary AI calls in parallel with standard care; safety cases are logged in real time by the Centre for Assuring Autonomy.
Sources (3)
- [1]New trial of AI phone assistant to monitor patients with long-term illness(https://medicalxpress.com/news/2026-11-trial-ai-patients-term-illness.html)
- [2]Safety assurance framework for autonomous clinical AI (Habli et al., 2024)(https://doi.org/10.1016/j.artmed.2024.102345)
- [3]Linguistic markers of clinician empathy in telephone consultations (Brandt et al., 2023)(https://doi.org/10.1016/j.pec.2023.107892)